These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

67 related articles for article (PubMed ID: 2402739)

  • 21. Effect of negatively charged activating compounds on inactivation of factor XIIa by Cl inhibitor.
    Pixley RA; Schmaier A; Colman RW
    Arch Biochem Biophys; 1987 Aug; 256(2):490-8. PubMed ID: 3497611
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The effect of chemical modification of basic amino acid residues on the activation and amidolytic activity of Hageman factor (factor XII).
    Ryder J; Everson B; Jentoft J; Ratnoff OD
    J Lab Clin Med; 1993 Dec; 122(6):697-702. PubMed ID: 8245689
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Inhibition of the cold activation of Factor VII and the prothrombin time.
    Palmer RN; Gralnick HR
    Am J Clin Pathol; 1984 May; 81(5):618-22. PubMed ID: 6202135
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The role of augmented Hageman factor (factor XII) titers in the cold-promoted activation of factor VII and spontaneous shortening of the prothrombin time in women using oral contraceptives.
    Gordon EM; Ratnoff OD; Jones PK
    J Lab Clin Med; 1982 Mar; 99(3):363-9. PubMed ID: 7057063
    [TBL] [Abstract][Full Text] [Related]  

  • 25. On the role of the C1-esterase inhibitor in cold urticaria.
    Nilsson T; Bäck O
    Acta Derm Venereol; 1984; 64(3):197-202. PubMed ID: 6204479
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Recombinant C1 inhibitor P5/P3 variants display resistance to catalytic inactivation by stimulated neutrophils.
    Eldering E; Huijbregts CC; Nuijens JH; Verhoeven AJ; Hack CE
    J Clin Invest; 1993 Mar; 91(3):1035-43. PubMed ID: 8450033
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Blood activation during neonatal extracorporeal life support.
    Plötz FB; van Oeveren W; Bartlett RH; Wildevuur CR
    J Thorac Cardiovasc Surg; 1993 May; 105(5):823-32. PubMed ID: 7683735
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Activation of the contact system and inflammation after thrombolytic therapy in patients with acute myocardial infarction.
    Merlini PA; Cugno M; Rossi ML; Agricola P; Repetto A; Fetiveau R; Diotallevi P; Canosi U; Mannucci PM; Ardissino D
    Am J Cardiol; 2004 Apr; 93(7):822-5. PubMed ID: 15050482
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The pathogenesis of hereditary angioedema.
    Davis AE
    Transfus Apher Sci; 2003 Dec; 29(3):195-203. PubMed ID: 14572810
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Mechanisms of bradykinin generation in human plasma.
    Kaplan AP
    Monogr Allergy; 1983; 18():272-6. PubMed ID: 6358866
    [No Abstract]   [Full Text] [Related]  

  • 31. Relative contribution of contact and complement activation to inflammatory reactions in arthritic joints.
    Abbink JJ; Kamp AM; Nuijens JH; Erenberg AJ; Swaak AJ; Hack CE
    Ann Rheum Dis; 1992 Oct; 51(10):1123-8. PubMed ID: 1444625
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Hageman factor and risk of myocardial infarction in middle-aged men.
    Kelleher CC; Mitropoulos KA; Imeson J; Meade TW; Martin JC; Reeves BE; Hughes LO
    Atherosclerosis; 1992 Nov; 97(1):67-73. PubMed ID: 1445495
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Epidemiological and genetic associations of activated factor XII concentration with factor VII activity, fibrinopeptide A concentration, and risk of coronary heart disease in men.
    Zito F; Drummond F; Bujac SR; Esnouf MP; Morrissey JH; Humphries SE; Miller GJ
    Circulation; 2000 Oct; 102(17):2058-62. PubMed ID: 11044420
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Role of contact system activation in hemodialyzer-induced thrombogenicity.
    Frank RD; Weber J; Dresbach H; Thelen H; Weiss C; Floege J
    Kidney Int; 2001 Nov; 60(5):1972-81. PubMed ID: 11703617
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Cold-induced contact surface activation of the prothrombin time in whole blood.
    Palmer RN; Gralnick HR
    Blood; 1982 Jan; 59(1):38-42. PubMed ID: 7053763
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Characterization of C1 inhibitor-Ta. A dysfunctional C1INH with deletion of lysine 251.
    Zahedi R; Aulak KS; Eldering E; Davis AE
    J Biol Chem; 1996 Sep; 271(39):24307-12. PubMed ID: 8798678
    [TBL] [Abstract][Full Text] [Related]  

  • 37. An association between the factor VII coagulant activity and thrombin activity induced by surface/cold exposure of normal human plasma.
    Miller GJ; Seghatchian MJ; Walter SJ; Howarth DJ; Thompson SG; Esnouf MP; Meade TW
    Br J Haematol; 1986 Feb; 62(2):379-84. PubMed ID: 3484967
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Factor XII: new life for an old protein.
    Schmaier AH; Larusch G
    Thromb Haemost; 2010 Nov; 104(5):915-8. PubMed ID: 20806112
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Studies on coagulation and fibrinolysis in pregnancy, with special reference to cold activation of factor VII.
    Gjonnaess H; Fagerhol MK
    Acta Obstet Gynecol Scand; 1975; 54(4):363-7. PubMed ID: 1081809
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Coupled amidolytic assay for factor VII: its use with a clotting assay to determine the activity state of factor VII.
    Seligsohn U; Osterud B; Rapaport SI
    Blood; 1978 Nov; 52(5):978-88. PubMed ID: 698402
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.